Treatment of hepatitis C in special populations.

Published

Journal Article (Review)

Hepatitis C virus (HCV) is a major cause of liver disease worldwide and is the most common chronic blood-borne infection in the United States. Experience has shown that the epidemiology and the response to treatment of HCV vary in certain patient groups. Differences have been observed in people from different racial and ethnic groups and in patients who have HIV and end-stage renal disease. These groups generally were not included in the early large clinical trials of HCV treatment. This article reviews recent findings in these patients groups and examines future directions.

Full Text

Duke Authors

Cited Authors

  • Ramamurthy, M; Muir, AJ

Published Date

  • November 2006

Published In

Volume / Issue

  • 10 / 4

Start / End Page

  • 851 - 865

PubMed ID

  • 17164121

Pubmed Central ID

  • 17164121

International Standard Serial Number (ISSN)

  • 1089-3261

Digital Object Identifier (DOI)

  • 10.1016/j.cld.2006.08.001

Language

  • eng

Conference Location

  • United States